Profiling of these cells revealed a switch from an immunosuppressive Th2 to a pro-inflammatory Th1 phenotype with increased ratios of INF-y to IL-4 in tumor-infiltrating CD4+ and CD8+ memory T-cells. Here, CD8A is linked to neoplasm.